TIG News and Press, TiGenix From 07/18/18

Mesoblast Limited ( MESO ) announced yesterday that it had entered into a partnership with China based Tasly Pharmaceutical Group . The deal gives Tasly exclusive rights in China for Mesoblast’s allogeneic mesenchymal precursor cell ((MPC)) product candidate MPC-150-IM for the indica...

Merger activity decreased last week with three new deals announced and seven pending deals closing. You can find all the active deals listed below in our Merger Arbitrage Tool (MAT) that automatically updates itself during market hours. There were no new deals announced in the Deals in th...